Cell Salvage System use in Minimally Invasive Myomectomy

Abstract

Study Objective The role of cell salvage use in gynecologic procedures, such as myomectomy, is not well established. We assessed the utilization and cost of cell salvage use in patients undergoing minimally invasive myomectomy from 2015 to 2018. Design Retrospective cohort study. Setting Academic medical center. Patients or Participants Patients who underwent minimally invasive myomectomy. Interventions Cell salvage use in minimally invasive myomectomy. Measurements and Main Results 382 patients underwent minimally invasive myomectomy; 67 cases (18%) had cell-salvage setup, with 30 of those patients (45%) reinfused. Nineteen units of perioperative allogenic blood transfusions occurred: 11U in the no cell-salvage set-up group, 5U in the cell-salvage set-up group, and 3U in the cell-salvage reinfusion group. The total volume of cell-salvage reinfusion was 9.5L (=32U PRBC). Patients with cell-salvage setup, compared to those without cell-salvage setup, had significantly higher median BMI (29.8 vs 27.6, p=0.02), larger mean maximum fibroid size (8.8cm vs 7.5cm, p Conclusion Cell-salvage system setup may be cost-effective during minimally invasive myomectomy. Maximum fibroid size is a possible preoperative indicator for patients who ultimately receive cell-salvage reinfusion.